State Street’s Aethlon Medical AEMD Stock Holding History

State Street’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-45	Closed	-$8.35K	–	4435
2023 Q3	$8.35K	Hold	45	–	–	﹤0.01%	4520
2023 Q2	$13.1K	Hold	45	–	–	﹤0.01%	4631
2023 Q1	$14K	Hold	45	–	–	﹤0.01%	4721
2022 Q4	$9.99K	Hold	45	–	–	﹤0.01%	4805
2022 Q3	$21K	Hold	45	–	–	﹤0.01%	4823
2022 Q2	$41K	Hold	45	–	–	﹤0.01%	4756
2022 Q1	$53K	Hold	45	–	–	﹤0.01%	4781
2021 Q4	$68K	Hold	45	–	–	﹤0.01%	4648
2021 Q3	$140K	Buy	45 +20	+80%	+$67.2K	﹤0.01%	4467
2021 Q2	$96K	Buy	+25	New	+$57.6K	﹤0.01%	4371

Other funds holding AEMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

State Street's AEMD Position: Q4 2023 in Review

State Street sold out of Aethlon Medical (AEMD) in Q4 2023, closing a stake of 45 shares — an estimated $8.35K sold.

State Street first reported a position in AEMD in Q2 2021 and held it in 10 quarters. The position peaked at $140K in Q3 2021. 10 funds tracked by Wall St. Rank hold AEMD as of Q4 2023.

State Street reported no remaining Aethlon Medical position as of Q4 2023 after selling out during the quarter.
State Street sold 45 Aethlon Medical shares in Q4 2023, an estimated $8.35K.
State Street first reported a position in Aethlon Medical in Q2 2021 and held it in 10 quarters.
State Street's Aethlon Medical position peaked at $140K in Q3 2021.
10 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.